Posttraumatische Belastungsstörung und Depression

F. Illes; I. Uhl

doi:10.1055/s-0037-1616408

Nervenheilkunde, Table of Contents

Nervenheilkunde 2016; 35(07/08): 474-480
DOI: 10.1055/s-0037-1616408

Trauma

Schattauer GmbH

Posttraumatische Belastungsstörung und Depression

Komorbidität, Symptomüberschneidung und therapeutische AnsatzpunktePosttraumatic stress disorder and major depressionMorbidity, symptom overlap and Therapeutic starting Points

F. Illes

¹LWL-Universitätsklinikum Bochum der Ruhr-Universität Bochum, Klinik für Psychiatrie, Psychotherapie und Präventivmedizin

,

I. Uhl

¹LWL-Universitätsklinikum Bochum der Ruhr-Universität Bochum, Klinik für Psychiatrie, Psychotherapie und Präventivmedizin

› Author Affiliations

Abstract

Zusammenfassung

Traumatische Ereignisse gehen mit einem erhöhten Risiko zur Entwicklung psychischer Erkrankungen einher. Posttraumatische Belastungsstörungen (PTBS) treten häufig mit komorbiden Diagnosen auf, insbesondere depressiven Erkrankungen. In dem Artikel werden die Komorbidität von PTBS und Depression, die Symptomüberlappung sowie therapeutische Möglichkeiten diskutiert.

Patienten, die in Folge eines traumatischen Ereignisses eine Depression oder PTBS entwickeln, haben ein erhöhtes Risiko für die jeweils andere Erkrankung. Eine hohe Symptomüberlappung zwischen beiden Störungsbildern ist zu beachten. Verschiedene Faktoren beeinflussen die Effekte eines traumatischen Ereignisses, z. B. die Art der Traumatisierung, das Alter beim Ereignis, Vorerkrankungen oder psychosoziale Stressoren. Psychologische, neuroendokrine und genetische Faktoren werden als Prädiktoren für die Auswirkungen eines traumatischen Ereignisses diskutiert.

Bei der psychotherapeutischen und pharmakologischen Behandlung sollte die Komorbidität berücksichtigt werden. Allerdings besteht weiterer Forschungsbedarf, um die therapeutischen Strategien für Patienten mit komorbiden Störungen zu optimieren.

Summary

Traumatic life events increase the risk of developing a psychiatric disease. Post traumatic stress disorder commonly co-occurs with other psychiatric disorders, particularly depressive disorders. In this paper, we discuss the comorbidity between PTSD and Major Depression, the symptom overlap and therapeutic options.

Patients with traumatic life events who suffer from either PTSD or Major Depression have an increased risk of developing the other disease respectively. However, there is a substantial amount of symptom overlap between both disorders.

Various factors may mediate the effect of a traumatic event, i.e. nature of trauma, age at trauma exposure, pre-existing diseases or psychosocial stress. Furthermore psychological, neuroendocrinological and genetic factors are discussed as predictors of reactions to trauma.

Accurate assessment of comorbidity may be important in determining optimal psychotherapeutic and pharmacotherapeutic treatment options for individuals with PTSD. However, further research is needed to optimize treatment outcomes of individuals with comorbid conditions.

Schlüsselwörter

Depression - posttraumatische Belastungsstörung - Komorbidität - Symptomüberschneidung

Keywords

Major depression - posttraumatic stress disorder - comorbidity - symptom overlap

Full Text

References

Literatur
1 Mahler J, Grabe HJ. Trauma und Depression. In: Seidler GH, Freyberger HJ, Maercker A. (Hrsg.) Handbuch der Psychotraumatologie. Stuttgart: Klett Cotta; 2011: 264-274
2 Perkonigg A, Kessler RC, Storz S, Wittchen HU. Traumatic events and posttraumatic stress disorder in the community: prevalence, risk factors and comorbidity. Acta Psychiatr Scand 2000; 101: 46-59.
3 Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry 1995; 52 (12) 1048-1060.
4 Shalev AY, Freedman S, Peri T, Brandes D, Sahar T, Orr SP, Pitman RK. Prospective study of posttraumatic stress disorder and depression following trauma. Am J Psychiatry 1998; 155 (05) 630-637.
5 Blanchard EB, Buckley TC, Hickling EJ, Taylor AE. Posttraumatic stress disorder and comorbid major depression: Is the correlation an illusion?. J Anxiety Disord 1998; 12 (01) 21-37.
6 Taft C, Resick P, Watkins L, Panuzio J. An investigation of posttraumatic stress disorder and depressive symptomatology among female victims of interpersonal trauma. J Fam Violence 2009; 1: 407-415.
7 Nixon RD, Resick PA, Nishith P. An exploration of comorbid depression among female victims of intimate partner violence with posttraumatic stress disorder. J Affect Disord 2004; 82: 315-320.
8 Kramer TL, Booth BM, Han X, Williams DK. Service utilization and outcomes in medically ill veterans with posttraumatic stress and depressive disorders. J Trauma Stress 2003; 16: 211-219.
9 Breslau N, Davis GC, Peterson EL, Schultz L. Psychiatric sequelae of posttraumatic stress disorder in women. Arch Gen Psychiatry 1997; 54 (01) 81-87.
10 King D, Leskin G, King L, Weathers F. Confirmatory factor analysis of the Clinician Administered PTSD Scale: Evidence for the dimensionality of Posttraumatic Stress Disorder. Psychological Assessment 1998; 10: 90-96.
11 Simms LJ, Watson D, Doebbeling BN. Confirmatory factoranalyses of posttraumatic stress symptoms in deployed and nondeployed veterans of the Gulf War. J Abnorm Psychol 2002; 111: 637-647.
12 Gros DF, Price M, Magruder KM, Frueh BC. Symptom overlap in posttraumatic stress disorder and major depression. Psychiatry Res 2012; 196 (2-3): 267-270.
13 Breslau N, Davis GC, Peterson EL, Schultz R. A second look at comorbidity in victims of trauma: The posttraumatic stress disorder-major depression connection. Biol Psychiatry 2000; 48 (09) 902-909.
14 Franklin CL, Zimmerman M. Posttraumatic stress disorder and major depressive disorder: Investigating the role of overlapping symptoms in diagnostic comorbidity. J Nerv Ment Dis 2001; 189: 548-551.
15 King DW, King LA, McArdle JJ, Shalev AY, Doron-Lamarca S. Sequential temporal dependencies in associations between symptoms of depression and posttraumatic stress disorder: an application of bivariate latent difference score structural equation modeling. Multivariate Behav Res 2009; 44: 437-464.
16 Grant DM, Beck JG, Marques L, Palyo SA, Clapp JD. The structure of distress following trauma: posttraumatic stress disorder, major depressive disorder, and generalized anxiety disorder. J Abnorm Psychol 2008; 17 (03) 662-672.
17 Green BL, Lindy JD, Grace MC, Gleser GC. Multiple diagnosis in posttraumatic stress disorder. The role of war stressors. J Nerv Ment Dis 1989; 177 (06) 329-335.
18 Smith EM, North CS, McCool RE, Shea JM. Acute postdiseaster psychiatric disorders: identification of persons at risk. Am J Psychiatry 1990; 147 (02) 202-226.
19 McFarlane AC, Papay P. Multiple diagnoses in posttraumtic stress disorder in the victims of a natural disaster. J Nerv Ment Dis 1992; 180 (08) 498-504.
20 Maercker A, Michael T, Fehm L, Becker ES, Margraf J. Age of traumatisation as a predictor of post-traumatic stress disorder or major depression in young women. Br J Psychiatry 2004; 184: 482-487.
21 Green BL, Korol M, Grace MC, Vary MG, Lonard AC, Gleser GC, Smitson-Cohen S. Children and disaster: Ache, gender and parental effects on PTSD symptoms. J Am Acad Child and Adolesc Psychiatry 1991; 30 (06) 945-951.
22 Seligman MEP. Erlernte Hilflosigkeit. München: Urban und Schwarzenberg; 1979
23 Heim C, Nemeroff CB. Neurobiology of posttraumatic stress disorder. CNS Spectr 2009; 14 (01) (Suppl. 01) 13-24 Review
24 Rinne T, de Kloet ER, Wouters L, Goekoop JG, DeRijk RH, van den Brink W. Hyperresponsiveness of hypothalamic-pituitary-adrenal axis to combined dexamethasone/corticotropin-releasing hormone challenge in female borderline personality disorder subjects with a history of sustained childhood abuse. Biol Psychiatry 2002; 52 (11) 1102-1112.
25 Ströhle A, Scheel M, Modell S, Holsboer F. Blunted ACTH response to dexamethasone suppression-CRH stimulation in posttraumatic stress disorder. J Psychiatr Res 2008; 42 (14) 1185-1188.
26 O’Donnell T, Hegadoren KM, Coupland NC. Noradrenergic mechanisms in the pathophysiology of post-traumatic stress disorder. Neuropsychobiology 2004; 50 (04) 273-283.
27 Newort DJ, Nemeroff CB. Neurobiology of posttraumatic stress disorder. Focus 2003; 1 (03) 313-321.
28 Neigh GN, Gillespie CF, Nemeroff CB. The neurobiological toll of child abuse and neglect. Trauma Violence Abuse 2009; 10 (04) 389-410.
29 Grossmann R, Yehuda R, Boisoneau D, Schmeidler J, Giller Jr EL. Prolactin response to low-dose dexamethasone challenge in combat-exposed veterans with and without posttraumatic stress disorder and normal controls. Biol Psychiatry 1996; 40: 1100-1105.
30 Lehrner A, Flory JD, Bierer LM, Makotkine I, Marmar CR, Yehuda R. Sexual dysfunction and neuroendocrine correlates of posttraumatic stress disorder in combat veterans: Preliminary findings. Psychoneuroendocrinology 2015; 63: 271-275.
31 Karlović D, Serretti A, Marčinko D, Martinac M, Silić A, Katinić K. Serum testosterone concentration in combat-related chronic posttraumatic stress disorder. Neuropsychobiology 2012; 65 (02) 90-95.
32 Hara E, Matsuoka Y, Hakamata Y, Nagamine M, Inagaki M, Imoto S, Murakami K, Kim Y, Uchitomi Y. Hippocampal and amygdalar volumes in breast cancer survivors with posttraumatic stress disorder. J Neuropsych and Clin Neurosci 2008; 20 (03) 302-308.
33 Amone D, McIntosh AM, Ebmeier KP, Munafò MR, Anderson IM. Magnetic resonance imaging studies in unipolar depression: systematic review and meta-regression analysis. Eur Neuropsychopharmacol 2012; 22 (01) 1-16.
34 Grabe HJ, Lange M, Wolff B, Volzke H, Lucht M, Freyberger HJ, John U, Cascorbi I. Mental and physical distress is modulated by a polymorphism in the 5-HT transporter gene interacting with social stressors and chronic disease burden. Mol Psychiatry 2005; 10 (02) 220-224.
35 Grabe HJ, Schwahn C, Appel K, Mahler J, Schulz A, Spitzer C, Barnow S, John U, Freyberger HJ, Rosskopf D, Volzke H. Update on the 2005 paper: Moderation of mental and physical distress by polymorphisms in the 5HT-transporter gene by interacting with social stressors and chronic disease burden. Mol Psychiatry 2011; 16 (04) 354-356.
36 Bradley RG, Binder EB, Epstein MP, Tang Y, Nair HP, Liu W, Gillespie CF, Berg T, Evces M, Newport DJ, Stowe ZN, Heim CM, Nemeroff CB, Schwartz A, Cubells JF, Ressler KJ. Influence of child abuse on adult depression: Moderation by the corticotrophin-releasing hormone receptor gene. Arch Gen Psychiatry 2008; 65 (02) 190-200.
37 Binder EB. The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders. Psychoneuroendocrinology 2009; 34 (Suppl. 01) 186-195.
38 Green BL, Krupnick JL, Chung J, Siddique J, Krause ED, Revicki D, Frank L, Miranda J. Impact of PTSD comorbidity on one-year outcomes in a depression trial. J Clin Psychol 2006; 62: 815-835.
39 Foa EB, Keane TM, Friedman MJ. et al. Effective Treatments for PTSD, Practice Guidelines from the International Society for Traumatic Stress Studies. New York: Guilford Press; 2009
40 Flatten G, Gast U, Hofmann A, Liebermann P, Reddemann L, Wöller S, Siol T, Petzold ER. Leitlinie Posttraumatische Belastungsstörung (Überarbeitete und aktualisierte Fassung) 2004. In: AWMF online: http://www.awmf.org/uploads/tx_szleitlinien/051-010k_S3_Posttraumatische_Belastungsstoerung_2012-03.pdf
41 Grawe K. Neuropsychotherapie. Göttingen: Hogrefe; 2004
42 Sack M. Schonende Traumatherapie. Stuttgart: Schattauer; 2010
43 Barlow DH, Farchione TJ, Fairholme CP, Ellard KK, Boisseau CL, Allen LB, Ehrenreich-May J. The Unified Protocol for Transdiagnostic Treatment of Emotional Disorders: Client Workbook. New York: Oxford University Press; 2011
44 McEvoy PM, Nathan P, Norton PJ. Efficacy of transdiagnostic treatments: A review of published outcome studies and future research directions. J Cogn Psychother 2009; 23: 27-40.
45 Farchione TJ, Fairholme CP, Ellard KK, Boisseau CL, Thompson-Hollands J, Carl JR, Gallagher MW, Barlow DH. Unified protocol for transdiagnostic treatment of emotional disorders: a randomized controlled trial. Behav Ther 2012; 43 (03) 666-678.
46 Norton PJ, Barrera TL. Transdiagnostic versus diagnosis-specific cbt for anxiety disorders: a preliminary randomized controlled noninferiority trial. Depress Anxiety 2012; 29 (10) 874-882.
47 Kip KE, Sullivan KL, Lengacher CA, Rosenzweig L, Hernandez DF, Kadel R, Kozel FA, Shuman A, Girling SA, Hardwick MJ, Diamond DM. Brief treatment of co-occurring post-traumatic stress and depressive symptoms by use of accelerated resolution therapy®. Front Psychiatry 2013; 4: 11.
48 Davidson JR. Pharmacologic treatment of acute and chronic stress following trauma: 2006. J Clin Psychiatry 2006; 67 (Suppl. 02) 34-39.
49 Tucker P, Ruwe WD, Masters B, Parker DE, Hossain A, Trautman RP, Wyatt DB. Neuroimmune and cortisol changes in selective serotonin reuptake inhibitor and placebo treatment of chronic posttraumatic stress disorder. Biol Psychiatry 2004; 56 (02) 121-128.
50 Davidson J, Baldwin D, Stein DJ, Kuper E, Benattia I, Ahmed S, Pedersen R, Musgnung J. Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial. Arch Gen Psychiatry 2006; 63 (10) 1158-1165.
51 Walderhaug E, Kasserman S, Aikins D, Vojvoda D, Nishimura C, Neumeister A. Effects of duloxetine in treatment-refractory men with posttraumatic stress disorder. Pharmacopsychiatry 2010; 43 (02) 45-49.
52 Asnis GM, Kohn SR, Henderson M, Brown NL. SSRIs versus non-SSRIs in post-traumatic stress disorder: an update with recommendations. Drugs 2004; 64 (04) 383-340.
53 Zhang W, Davidson JR. Post-traumatic stress disorder: an evaluation of existing pharmacotherapies and new strategies. Expert Opin Pharmacother 2007; 8 (12) 1861-1870.
54 Donnelly CL. Pharmacologic treatment approaches for children and adolescents with posttraumatic stress disorder. Child Adolesc Psychiatr Clin N Am 2003; 12 (02) 251-269.
55 Adamou M, Puchalska S, Plummer W, Hale AS. Valproate in the treatment of PTSD: systematic review and meta analysis. Curr Med Res Opin 2007; 23 (06) 1285-1291 Review
56 Han C, Pae CU, Wang SM, Lee SJ, Patkar AA, Masand PS, Serretti A. The potential role of atypical antipsychotics for the treatment of posttraumatic stress disorder. J Psychiatr Res 2014; 56: 72-81.
57 Berger W, Mendlowicz MV, Marques-Portella C, Kinrys G, Fontenelle LF, Marmar CR, Figueira I. Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: a systematic review. Prog Neuropsychopharmacol Biol Psychiatry 2009; 33 (02) 169-180.
58 Zohar J, Fostick L, Cohen A, Bleich A, Dolfin D, Weissman Z, Doron M, Kaplan Z, Klein E, Shalev AY. Israeli Consortium on PTSD. Risk factors for the development of posttraumatic stress disorder following combat trauma: a semiprospective study. J Clin Psychiatry 2009; 70 (12) 1629-1635.